Vaccine Research On HIV/AIDS
An HIV
vaccine is either a preventive
vaccine or a therapeutic vaccine, which suggests it will either defend people from being infected with HIV or treat HIV-infected people. And it will either induce associate response against HIV or accommodates preformed antibodies against HIV. The trademark of an infective agent
vaccine is to elicit sturdy, effective and intensive immune responses against the virus. A technique of demonstrating that antibodies will elicit protection is by passive
administration followed by virus challenge in in vivo models. A
vaccine capable of eliciting satisfactory levels of protein against HIV-1 might forestall the institution of infection. Within the case of HIV-1 the event of a good
vaccine has been associate elusive one in the main because of the substance and
genetic diversity of the virus.
High Impact List of Articles
Relevant Topics in Clinical